Ilumya

List of products in the National Drug Code with proprietary name ilumya. This medication is used to treat moderate to severe plaque psoriasis. Tildrakizumab-asmn belongs to a class of drugs known as monoclonal antibodies. It works by blocking a certain natural substance in your body (interleukin-23) that may lead to the overgrowth of skin cells and redness/swelling seen in plaque psoriasis. Tildrakizumab-asmn can help lessen the symptoms of plaque psoriasis, including red, scaly, itchy patches of skin.

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Labeler Name Product Type
47335-177Ilumya Tildrakizumab-asmnInjection, SolutionSubcutaneousSun Pharmaceutical Industries, Inc.Human Prescription Drug